Page last updated: 2024-09-03

ezogabine and sb 705498

ezogabine has been researched along with sb 705498 in 1 studies

Compound Research Comparison

Studies
(ezogabine)
Trials
(ezogabine)
Recent Studies (post-2010)
(ezogabine)
Studies
(sb 705498)
Trials
(sb 705498)
Recent Studies (post-2010) (sb 705498)
3832624135724

Protein Interaction Comparison

ProteinTaxonomyezogabine (IC50)sb 705498 (IC50)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)0.032
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)1.6
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)0.0546

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, J; Guo, Y; Hu, X; Huang, H; Jin, Z; Li, Z; Liu, Z; Wang, K; Wang, Y; Zhang, L; Zhong, Y; Zong, X1

Other Studies

1 other study(ies) available for ezogabine and sb 705498

ArticleYear
Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Analgesics; Animals; Anoctamin-1; Carboxylic Acids; HEK293 Cells; Humans; Hyperalgesia; Mice; Neoplasm Proteins; Pain

2022